Cita APA

Hoshino, M., Haraguchi, Y., Sakai, M., Hayashi, K., Horita, N., Miyayama, N., . . . Ohsawa, H. (2000). Hypercoagulability indicated by elevated blood TFPI (tissue factor pathway inhibitor) levels is closely related to severity of septic patients with glucose intolerance. BioMed Central.

Citación estilo Chicago

Hoshino, M., Y. Haraguchi, M. Sakai, K. Hayashi, N. Horita, N. Miyayama, H. Saegusa , y H. Ohsawa. Hypercoagulability Indicated By Elevated Blood TFPI (tissue Factor Pathway Inhibitor) Levels Is Closely Related to Severity of Septic Patients With Glucose Intolerance. BioMed Central, 2000.

Cita MLA

Hoshino, M., et al. Hypercoagulability Indicated By Elevated Blood TFPI (tissue Factor Pathway Inhibitor) Levels Is Closely Related to Severity of Septic Patients With Glucose Intolerance. BioMed Central, 2000.